Rainer Klaus Reinscheid

Title: The Innovations of Rainer Klaus Reinscheid

Introduction

Rainer Klaus Reinscheid is an esteemed inventor based in Eimeldingen, Germany. He has made significant contributions to the field of pharmacology through his innovative research in opioid receptor ligands. His work has resulted in a patent that enhances our understanding of mammalian opioid receptors and their potential therapeutic applications.

Latest Patents

Reinscheid holds a patent for a "Mammalian opioid receptor ligand and uses." This groundbreaking invention pertains to a novel mammalian opioid receptor protein and the ligands that bind to it. The patent details the isolation and characterization of an endogenous ligand that specifically attaches to a newly discovered mammalian opioid receptor protein expressed in mammalian cells. Moreover, the invention includes isolated peptide ligands, showcasing variants that can be radioiodinated, alongside methods for their synthesis and applications in diagnostics and therapy.

Career Highlights

Rainer Klaus Reinscheid's career is marked by his association with the Oregon Health & Science University. His research and innovations have significant implications for understanding opioid receptors, thereby contributing to the development of effective opioid therapies. His patent is a testament to his dedication to advancing medical science and public health.

Collaborations

Throughout his career, Reinscheid has collaborated with notable researchers, including David K. Grandy and James R. Bunzow. These collaborations have facilitated advancements in the understanding of receptor biology, enhancing the quality and impact of his research.

Conclusion

Rainer Klaus Reinscheid’s contributions to the field of pharmacology through his patent for mammalian opioid receptor ligands highlight the importance of innovations in medicine. His ongoing collaboration with esteemed colleagues and commitment to research at the Oregon Health & Science University continue to enrich the scientific community and advance therapeutic possibilities for opioid-related treatments.